Table 2.

Sites of metastatic disease according to age at time of clinical diagnosis

Site of metastasis	Age (years) at clinical diagnosis (n = 180)			p
	49 or younger	50–64	65 or older
	(n = 77)	(n = 71)	(n = 32)
Lung or pleura
No	14 (18.2%)	14 (19.7%)	10 (31.3%)
Yes	63 (81.8%)	57 (80.3%)	22 (68.8%)	0.29
Bone
No	15 (19.5%)	26 (36.6%)	5 (15.6%)
Yes	62 (80.5%)	45 (63.4%)	27 (84.4%)	0.021
Liver
No	13 (16.9%)	20 (28.2%)	18 (56.3%)
Yes	64 (83.1%)	51 (71.8%)	14 (43.8%)	<0.001
Non-axillary nodes
No	37 (48.1%)	26 (36.6%)	18 (56.3%)
Yes	40 (51.9%)	45 (63.4%)	14 (43.8%)	0.14
Adrenal glands
No	35 (45.5%)	39 (54.9%)	24 (75.0%)
Yes	42 (54.5%)	32 (45.1%)	8 (25.0%)	0.019
CNS
No	54 (70.1%)	59 (83.1%)	26 (81.3%)
Yes	23 (29.9%)	12 (16.9%)	6 (18.8%)	0.14
Gynae organs
No	54 (70.1%)	65 (91.5%)	30 (93.8%)
Yes	23 (29.9%)	6 (8.5%)	2 (6.3%)	0.001
Number of metastatic sites
0–3	12 (15.6%)	24 (33.8%)	17 (53.1%)
4–5	33 (42.8%)	26 (36.6%)	8 (25.0%)
6–13	32 (41.6%)	21 (29.6%)	7 (21.9%)	0.002